HbA1c 0 5 0 5 B-clinical_variable
of 6 8 6 8 O
greater 9 16 9 16 O
than 17 21 17 21 O
or 22 24 22 24 O
equal 25 30 25 30 O
to 31 33 31 33 O
( 34 35 34 35 O
> 35 36 35 36 O
=) 36 38 36 38 O
6.5 38 41 38 41 B-lower_bound
percent 42 49 42 49 I-lower_bound
( 50 51 50 51 I-lower_bound
% 51 52 51 52 I-lower_bound
) 52 53 52 53 I-lower_bound
to 54 56 54 56 O
less 57 61 57 61 O
than 62 66 62 66 O
or 67 69 67 69 O
equal 70 75 70 75 O
to 76 78 76 78 O
( 79 80 79 80 O
< 80 81 80 81 O
=) 81 83 81 83 O
10.5 83 87 83 87 B-upper_bound
% 87 88 87 88 I-upper_bound

On 0 2 89 91 O
diet 3 7 92 96 O
and 8 11 97 100 O
exercise 12 20 101 109 O
alone 21 26 110 115 O
during 27 33 116 122 O
the 34 37 123 126 O
8 38 39 127 128 B-upper_bound
weeks 40 45 129 134 I-upper_bound
prior 46 51 135 140 I-upper_bound
to 52 54 141 143 O
screening 55 64 144 153 O

Participants 0 12 154 166 O
on 13 15 167 169 O
any 16 19 170 173 O
antihyperglycemic 20 37 174 191 B-treatment
agents 38 44 192 198 I-treatment
( 45 46 199 200 I-treatment
AHAs 46 50 200 204 I-treatment
) 50 51 204 205 I-treatment
other 52 57 206 211 O
than 58 62 212 216 O
metformin 63 72 217 226 B-treatment
, 72 73 226 227 O
or 74 76 228 230 O
injectable 77 87 231 241 B-treatment
insulin 88 95 242 249 I-treatment
within 96 102 250 256 O
8 103 104 257 258 B-upper_bound
weeks 105 110 259 264 I-upper_bound
of 111 113 265 267 O
the 114 117 268 271 O
first 118 123 272 277 O
dose 124 128 278 282 O
of 129 131 283 285 O
study 132 137 286 291 B-treatment
drug 138 142 292 296 I-treatment
( 143 144 297 298 O
that 144 148 298 302 O
is 149 151 303 305 O
Day 152 155 306 309 O
1 156 157 310 311 O
) 157 158 311 312 O

Participants 0 12 313 325 O
with 13 17 326 330 O
a 18 19 331 332 O
diagnosis 20 29 333 342 O
of 30 32 343 345 O
type 33 37 346 350 B-chronic_disease
2 38 39 351 352 I-chronic_disease
diabetes 40 48 353 361 I-chronic_disease
mellitus 49 57 362 370 I-chronic_disease
( 58 59 371 372 I-chronic_disease
T2DM 59 63 372 376 I-chronic_disease
) 63 64 376 377 I-chronic_disease

Random 0 6 378 384 O
C 7 8 385 386 B-clinical_variable
- 8 9 386 387 I-clinical_variable
peptide 9 16 387 394 I-clinical_variable
at 17 19 395 397 O
screening 20 29 398 407 O
greater 30 37 408 415 O
than 38 42 416 420 O
( 43 44 421 422 O
> 44 45 422 423 O
) 45 46 423 424 O
0.6 46 49 424 427 B-lower_bound
nanogram 50 58 428 436 I-lower_bound
/ 58 59 436 437 I-lower_bound
milliliter 59 69 437 447 I-lower_bound
( 70 71 448 449 I-lower_bound
ng 71 73 449 451 I-lower_bound
/ 73 74 451 452 I-lower_bound
mL 74 76 452 454 I-lower_bound
) 76 77 454 455 I-lower_bound
( 78 79 456 457 O
> 79 80 457 458 O
0.2 80 83 458 461 B-lower_bound
nanomole 84 92 462 470 I-lower_bound
/ 92 93 470 471 I-lower_bound
liter 93 98 471 476 I-lower_bound
[ 99 100 477 478 I-lower_bound
nmol]/L 100 107 478 485 I-lower_bound
] 107 108 485 486 I-lower_bound
) 108 109 486 487 O

Repeated 0 8 488 496 O
( 9 10 497 498 O
2 10 11 498 499 B-lower_bound
or 12 14 500 502 O
more 15 19 503 507 O
over 20 24 508 512 O
a 25 26 513 514 O
1 27 28 515 516 O
- 28 29 516 517 O
week 29 33 517 521 O
period 34 40 522 528 O
) 40 41 528 529 O
fasting 42 49 530 537 O
self 50 54 538 542 B-clinical_variable
- 54 55 542 543 I-clinical_variable
monitoring 55 65 543 553 I-clinical_variable
of 66 68 554 556 I-clinical_variable
blood 69 74 557 562 I-clinical_variable
glucose 75 82 563 570 I-clinical_variable
( 83 84 571 572 I-clinical_variable
SMBG 84 88 572 576 I-clinical_variable
) 88 89 576 577 I-clinical_variable
measurements 90 102 578 590 I-clinical_variable
> 103 104 591 592 O
270 104 107 592 595 B-lower_bound
milligram 108 117 596 605 I-lower_bound
/ 117 118 605 606 I-lower_bound
deciliter 118 127 606 615 I-lower_bound
( 128 129 616 617 I-lower_bound
mg 129 131 617 619 I-lower_bound
/ 131 132 619 620 I-lower_bound
dL 132 134 620 622 I-lower_bound
) 134 135 622 623 I-lower_bound
( 136 137 624 625 O
> 137 138 625 626 O
15 138 140 626 628 B-lower_bound
millimole 141 150 629 638 I-lower_bound
/ 150 151 638 639 I-lower_bound
liter 151 156 639 644 I-lower_bound
[ 157 158 645 646 I-lower_bound
mmol 158 162 646 650 I-lower_bound
/ 162 163 650 651 I-lower_bound
L 163 164 651 652 I-lower_bound
] 164 165 652 653 I-lower_bound
) 165 166 653 654 O
during 167 173 655 661 O
the 174 177 662 665 O
pretreatment 178 190 666 678 O
phase 191 196 679 684 O
, 196 197 684 685 O
despite 198 205 686 693 O
reinforcement 206 219 694 707 O
of 220 222 708 710 O
diet 223 227 711 715 O
and 228 231 716 719 O
exercise 232 240 720 728 O
counseling 241 251 729 739 O

Severe 0 6 740 746 B-chronic_disease
hypoglycemia 7 19 747 759 I-chronic_disease
within 20 26 760 766 O
6 27 28 767 768 B-upper_bound
months 29 35 769 775 I-upper_bound
prior 36 41 776 781 I-upper_bound
to 42 44 782 784 O
Day 45 48 785 788 O
1 49 50 789 790 O

stable 0 6 791 797 O
dose 7 11 798 802 O
of 12 14 803 805 O
metformin 15 24 806 815 B-clinical_variable
monotherapy 25 36 816 827 I-clinical_variable
> 37 38 828 829 O
= 38 39 829 830 O
1,000 39 44 830 835 B-lower_bound
mg 45 47 836 838 I-lower_bound
per 48 51 839 842 I-lower_bound
day 52 55 843 846 I-lower_bound
or 56 58 847 849 O
MTD 59 62 850 853 O
per 63 66 854 857 O
day 67 70 858 861 O
for 71 74 862 865 O
at 75 77 866 868 O
least 78 83 869 874 O
8 84 85 875 876 B-lower_bound
weeks 86 91 877 882 I-lower_bound
prior 92 97 883 888 I-lower_bound
to 98 100 889 891 O
screening 101 110 892 901 O

stable 0 6 902 908 O
insulin 7 14 909 916 B-treatment
monotherapy 15 26 917 928 I-treatment
regimen 27 34 929 936 I-treatment
for 35 38 937 940 O
at 39 41 941 943 O
least 42 47 944 949 O
8 48 49 950 951 B-lower_bound
weeks 50 55 952 957 I-lower_bound
prior 56 61 958 963 I-lower_bound
to 62 64 964 966 O
screening 65 74 967 976 O
( 75 76 977 978 O
stable 76 82 978 984 O
dose 83 87 985 989 O
is 88 90 990 992 O
defined 91 98 993 1000 O
as 99 101 1001 1003 O
no 102 104 1004 1006 O
change 105 111 1007 1013 O
in 112 114 1014 1016 O
the 115 118 1017 1020 O
insulin 119 126 1021 1028 B-clinical_variable
regimen 127 134 1029 1036 I-clinical_variable
[ 135 136 1037 1038 O
ie 136 138 1038 1040 O
, 138 139 1040 1041 O
type{s 140 146 1042 1048 O
} 146 147 1048 1049 O
of 148 150 1050 1052 O
insulin 151 158 1053 1060 O
] 158 159 1060 1061 O
and 160 163 1062 1065 O
< 164 165 1066 1067 O
= 165 166 1067 1068 O
15 166 168 1068 1070 B-upper_bound
% 168 169 1070 1071 I-upper_bound
change 170 176 1072 1078 O
in 177 179 1079 1081 O
the 180 183 1082 1085 O
total 184 189 1086 1091 O
daily 190 195 1092 1097 O
dose 196 200 1098 1102 O
of 201 203 1103 1105 O
insulin 204 211 1106 1113 O
[ 212 213 1114 1115 O
averaged 213 221 1115 1123 O
over 222 226 1124 1128 O
1 227 228 1129 1130 B-lower_bound
week 229 233 1131 1135 I-lower_bound
to 234 236 1136 1138 O
account 237 244 1139 1146 O
for 245 248 1147 1150 O
day 249 252 1151 1154 O
to 253 255 1155 1157 O
day 256 259 1158 1161 O
variability 260 271 1162 1173 O
] 271 272 1173 1174 O
) 272 273 1174 1175 O

